Biocom - Life Sciences Association of California
Close
Call
Profile
San Diego  |   Los Angeles  |   Washington, DC  |   Tokyo
cONTENT bLOCK
Left
Left

Newsroom

articles of interest
From the Bcq
Bill will move to House Budget Committee to review and consolidate bill next week.

Bills on the list: Drug and sharps takeback programs, drug pricing, repeal of CA Stem Cell Research and Cures Act, ban on drug co-pay coupons, and opioid addiction manufacturers tax.

Garcetti secured more than 80% of votes for an unprecedented win.

Director for Drug Evaluations and Research and panels of industry reps discussed benefits of GDUFA I and BsUFA II and concerns of drug prices.

Join 300+ Facilities professionals and check out 150 service providers from a full gamut of different service areas.

Biocom team is working to quickly progress the proposal to allow greater utilization of industrial lands by companies.

Partnership will build on already well established relationship and connect two regions for increased business opportunities.

Public policy Newsletter

Biocom's Public Policy Newsletter is a once-monthly, members-only publication offering a snapshot of how Biocom is engaging at all levels of government in both the legislative and regulatory worlds.


If you are interested in receiving the Public Policy Newsletter, please email Emily Cassel at ecassel@biocom.org.

Upcoming Public Policy Events
calendar-icon.png
Apr
5
Oncology Advocacy Fly-In
Wednesday
April 5, 2017
4:00 PM